Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
National Cancer Institute (NCI)
National Cancer Institute (NCI)
The New York Proton Center
University of Arizona
Pfizer
National Institutes of Health Clinical Center (CC)
Conjupro Biotherapeutics, Inc.
AstraZeneca
Pfizer
Dragonfly Therapeutics
PMV Pharmaceuticals, Inc
Hoffmann-La Roche
UMC Utrecht
ViroMissile, Inc.
Luzerner Kantonsspital
Duke University
Washington University School of Medicine
Tizona Therapeutics, Inc
IDEAYA Biosciences
University of Colorado, Denver
Adaptimmune
xCures
Daiichi Sankyo
Oscotec Inc.
Kidney Cancer Research Bureau
Adela, Inc
Natera, Inc.
Second Life Therapeutics
Elephas
Novartis
Elephas
Inhibrx Biosciences, Inc
RenJi Hospital
XEOS Medical
Gustave Roussy, Cancer Campus, Grand Paris
University Health Network, Toronto
National Institutes of Health Clinical Center (CC)
BicycleTx Limited
University of Colorado, Denver
Bolt Biotherapeutics, Inc.
Tempus AI
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center
ITM Oncologics GmbH
Actym Therapeutics, Inc.
Maastricht University Medical Center
Maastricht Radiation Oncology
Washington University School of Medicine
Washington University School of Medicine
Palleon Pharmaceuticals, Inc.
Exelixis